{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:45:23Z","timestamp":1794379523444,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (PHPT) is a common endocrine disorder caused by a parathyroid tumor or hyperplasia, which is often accompanied with quality of life (QoL) impairment. A parathyroidectomy (PTX) is the preferred standard treatment for PHPT patients. In this single center study we aimed to evaluate the impact of PHPT on patient\u2019s QoL and identify QoL changes at early and long-term follow-up after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All the patients underwent routine PTX with the removal of the suspected hyperparathyroid gland(s). Patients filled out generic QoL questionnaire RAND SF-36, specific questionnaire PHPQoL and specific symptom assessment questionnaire PAS upon admission to the hospital before surgery, at 3\u00a0months, 12\u00a0months and 24\u00a0months after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 92 patients with PHPT (median age was 56\u00a0years, 95.7% females) were included in the study. Before PTX patient\u2019s QoL by SF-36 scores was significantly lower as compared to healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Almost 40% of patients had poor or very poor QoL. The most frequent symptoms by PAS before surgery were as follows: tiredness (97.8% of patients), weakness (94.6%), forgetfulness (94.6%), mood changes (90%), feeling \u201cblue\u201d\/depression (88%), joint pains (83.3%), headaches (80.2%), constant irritability (77.2%), bone pains (75%), thirst (70.7%) and trouble getting out of a chair (67.4%). The half of the patients had moderate-to-severe (\u2265\u200940 scores) tiredness, weakness, joint pains, forgetfulness, as well as mood changes. Post-operative QoL changes were analysed in the group of 72 patients. After surgery there was significant improvement in QoL by all scales of SF-36 questionnaire, excluding bodily pain, and the PHPQoL total score (GEE,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) as compared with their values before surgery. Also severity of tiredness, mood changes, weakness and forgetfulness significantly decreased after surgery as compared to their baseline values (GEE,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Decreased mental component of QoL by PHPQoL (OR\u2009=\u20090.927, 95%CI\u2009=\u20090.874\u20130.984,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013) predicted improved QoL after surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with PHPT demonstrated significantly impaired QoL in physical, psychological and social functioning as well experienced a wide profile of common PHPT symptoms. Successful PTX was accompanied with remarkable QoL improvement and decrease in subjective symptoms for at least 24\u00a0months after surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-023-01344-z","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:14:36Z","timestamp":1682036076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-5286","authenticated-orcid":false,"given":"T. I.","family":"Ionova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8350-8376","authenticated-orcid":false,"given":"D. M.","family":"Buzanakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3001-664X","authenticated-orcid":false,"given":"R. A.","family":"Chernikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5581-9169","authenticated-orcid":false,"given":"S. M.","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-6401","authenticated-orcid":false,"given":"I. N.","family":"Gladkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8279-8129","authenticated-orcid":false,"given":"T. P.","family":"Nikitina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-5081","authenticated-orcid":false,"given":"I. V.","family":"Sleptsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1259-8188","authenticated-orcid":false,"given":"A. V.","family":"Zolotoukho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-150X","authenticated-orcid":false,"given":"K. A.","family":"Bubnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-8962","authenticated-orcid":false,"given":"V. V.","family":"Skvortsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4259-6001","authenticated-orcid":false,"given":"A. A.","family":"Vinogradova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-778X","authenticated-orcid":false,"given":"V. F.","family":"Rusakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14:115\u201325.","journal-title":"Nat Rev Endocrinol"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1210\/jc.2008-2291","volume":"94","author":"SH Golden","year":"2009","unstructured":"Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Prevalence and Incidence of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review. J Clin Endocrinol Metab. 2009;94:1853\u201378.","journal-title":"J Clin Endocrinol Metab"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijsu.2014.12.004","volume":"13","author":"K Brito","year":"2015","unstructured":"Brito K, Edirimanne S, Eslick GD. The extent of improvement of health-related quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism \u2013 A systematic review and meta-analysis. Int J Surg. 2015;13:245\u20139.","journal-title":"Int J Surg"},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/EC-15-0053","volume":"4","author":"EM Ryh\u00e4nen","year":"2015","unstructured":"Ryh\u00e4nen EM, Heiskanen I, Sintonen H, V\u00e4lim\u00e4ki MJ, Roine RP, Schalin-J\u00e4ntti C. Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument. Endocr Connect. 2015;4:179\u201386.","journal-title":"Endocr Connect"},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cen.13865","volume":"90","author":"H Ejlsmark-Svensson","year":"2019","unstructured":"Ejlsmark-Svensson H, Sikjaer T, Webb SM, Rejnmark L, Rolighed L. Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study. Clin Endocrinol (Oxf). 2019;90:184\u201391.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1507\/endocrj.EJ20-0417","volume":"68","author":"E Somuncu","year":"2021","unstructured":"Somuncu E, Kara Y. The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire. Endocr J. 2021;68:87\u201393.","journal-title":"Endocr J"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jss.2020.12.023","volume":"261","author":"B Vadhwana","year":"2021","unstructured":"Vadhwana B, Currow C, Bowers D, Groot-Wassink T. Impact on Quality of Life After Parathyroidectomy for Asymptomatic Primary Hyperparathyroidism. J Surg Res. 2021;261:139\u201345.","journal-title":"J Surg Res"},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1210\/jc.2015-3094","volume":"101","author":"SM Webb","year":"2016","unstructured":"Webb SM, Puig-Domingo M, Villabona C, Mu\u00f1oz-Torres M, Marazuela M, Fern\u00e1ndez D, et al. Validation of PHPQoL, a Disease-Specific Quality-of-Life Questionnaire for Patients With Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2016;101:1571\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00405-007-0523-6","volume":"265","author":"K Tsukahara","year":"2008","unstructured":"Tsukahara K, Sugitani I, Fujimoto Y, Kawabata K. Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism. Eur Arch Otorhinolaryngol. 2008;265:565\u20139.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7525-11-97","volume":"11","author":"SM Webb","year":"2013","unstructured":"Webb SM, Puig-Domingo M, Villabona C, Mu\u00f1oz-Torres M, Farrerons J, Badia X. Development of a new tool for assessing Health-Related Quality of Life in patients with primary hyperparathyroidism. Health Qual Life Outcomes. 2013;11:97.","journal-title":"Health Qual Life Outcomes"},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","volume":"26","author":"JL Pasieka","year":"2002","unstructured":"Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, et al. Patient-based Surgical Outcome Tool Demonstrating Alleviation of Symptoms following Parathyroidectomy in Patients with Primary Hyperparathyroidism. World J Surg. 2002;26:942\u20139.","journal-title":"World J Surg"},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37:2293\u2013314.","journal-title":"J Bone Miner Res"},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s00423-022-02711-5","volume":"407","author":"DM Buzanakov","year":"2022","unstructured":"Buzanakov DM, Sleptsov IV, Semenov AA, Chernikov RA, Novokshonov KY, Karelina YV, et al. Persistence of primary hyperparathyroidism: a single-center experience. Langenbecks Arch Surg. 2022;407:3651\u20139.","journal-title":"Langenbecks Arch Surg"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4158\/EP.13.4.338","volume":"13","author":"EA Mittendorf","year":"2007","unstructured":"Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, et al. Improvement of Sleep Disturbance and Neurocognitive Function after Parathyroidectomy in Patients with Primary Hyperparathyroidism. Endocr Pract. 2007;13:338\u201344.","journal-title":"Endocr Pract"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.amjsurg.2008.09.009","volume":"197","author":"JT Adler","year":"2009","unstructured":"Adler JT, Sippel RS, Schaefer S, Chen H. Surgery improves quality of life in patients with \u201cmild\u201d hyperparathyroidism. Am J Surg. 2009;197:284\u201390.","journal-title":"Am J Surg"},{"key":"1344_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00268-013-2285-1","volume":"38","author":"SE Murray","year":"2014","unstructured":"Murray SE, Pathak PR, Schaefer SC, Chen H, Sippel RS. Improvement of Sleep Disturbance and Insomnia Following Parathyroidectomy for Primary Hyperparathyroidism. World J Surg. 2014;38:542\u20138.","journal-title":"World J Surg"},{"key":"1344_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.4199","volume":"36","author":"M Pretorius","year":"2021","unstructured":"Pretorius M, Lundstam K, Hellstr\u00f6m M, Fagerland MW, Godang K, Mollerup C, et al. Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the <scp>SIPH<\/scp> -Study). J Bone Miner Res. 2021;36:3\u201311.","journal-title":"J Bone Miner Res"},{"key":"1344_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.4249","author":"J Livschitz","year":"2022","unstructured":"Livschitz J, Yen TWF, Evans DB, Wang TS, Dream S. Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review. JAMA Surg. 2022. https:\/\/doi.org\/10.1001\/jamasurg.2022.4249.","journal-title":"JAMA Surg"},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1344_CR20","volume-title":"User\u2019s Manual for Medical Outcomes Study (MOS) Core measures of health-related quality of life. MR-162-RC","author":"RD Hays","year":"1995","unstructured":"Hays RD, Sherbourne CD, Mazel RM. User\u2019s Manual for Medical Outcomes Study (MOS) Core measures of health-related quality of life. MR-162-RC. 1995."},{"key":"1344_CR21","unstructured":"Novik AA, Ionova TI. Guidelines for Quality of Life Research in Medicine (4th ed., rev. and ad.)\/Ed. Yu.L. Shevchenko). Pirogov National Medical and Surgical Centre Publ; 2021."},{"key":"1344_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","volume":"33","author":"LA Erickson","year":"2022","unstructured":"Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO Classification of Parathyroid Tumors. Endocr Pathol. 2022;33:64\u201389.","journal-title":"Endocr Pathol"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"M Calvert","year":"2013","unstructured":"Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, et al. Reporting of Patient-Reported Outcomes in Randomized Trials. JAMA. 2013;309:814.","journal-title":"JAMA"},{"key":"1344_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.4225","volume":"36","author":"MD Walker","year":"2021","unstructured":"Walker MD, Silverberg SJ. Quality of Life in Primary Hyperparathyroidism Revisited: Keep Calm and Carry on? J Bone Miner Res. 2021;36:1\u20132.","journal-title":"J Bone Miner Res"},{"key":"1344_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","volume":"141","author":"C Caillard","year":"2007","unstructured":"Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, et al. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007;141:153\u201360.","journal-title":"Surgery"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/bjs.10739","volume":"105","author":"S Bannani","year":"2018","unstructured":"Bannani S, Christou N, Gu\u00e9rin C, Hamy A, Sebag F, Mathonnet M, et al. Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg. 2018;105:223\u20139.","journal-title":"Br J Surg"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jss.2021.01.029","volume":"263","author":"KB Montgomery","year":"2021","unstructured":"Montgomery KB, Fazendin JM, Lindeman B, Chen H. Tired of Being Ignored: Fatigue as a Presenting Symptom in Primary Hyperparathyroidism. J Surg Res. 2021;263:53\u20136.","journal-title":"J Surg Res"},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.eprac.2021.01.003","volume":"27","author":"G Tzikos","year":"2021","unstructured":"Tzikos G, Chorti A, Evangelos S, Boura E, Manani C, Adamidou F, et al. Quality of Life in Patients With Asymptomatic Primary Hyperparathyroidism After Parathyroidectomy: A 3-Year Longitudinal Study. Endocr Pract. 2021;27:716\u201322.","journal-title":"Endocr Pract"},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.47717\/turkjsurg.2021.5156","volume":"37","author":"B Mohan","year":"2021","unstructured":"Mohan B, Abuji K, Dahiya D, Tandup C, Bhadada S, Behera A. Quality of life assessment after parathyroidectomy in symptomatic primary hyperparathyroidism using the SF-36 questionnaire. Turk J Surg. 2021;37:247\u201352.","journal-title":"Turk J Surg"},{"key":"1344_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14341\/probl12825","volume":"68","author":"TP Nikitina","year":"2022","unstructured":"Nikitina TP, Gladkova IN, Rusakov VF, Chernikov RA, Karelina YuV, Efremov SM, et al. Quality of life in patients with primary hyperparathyroidism after surgery. Probl Endocrinol. 2022;68:27\u201339.","journal-title":"Probl Endocrinol"},{"key":"1344_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00019053-200018050-00001","volume":"18","author":"RD Hays","year":"2000","unstructured":"Hays RD, Woolley JM. The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research. Pharmacoeconomics. 2000;18:419\u201323.","journal-title":"Pharmacoeconomics"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01344-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:18:11Z","timestamp":1682036291000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01344-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"26 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and Informed Consent form were approved by the local Ethics Committee of the Saint-Petersburg State University Hospital (Journal-no: 08\/19, date of approval: 15 August 2019). All the patients provided written informed consent prior to enrollment. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}